ArQule to Release Data at the 2018 American Association for Cancer Research (AACR) Annual Meeting

According to a media release, data will be presented in one oral and nine poster sessions on trials conducted by ArQule and its collaborators for BTK inhibitor, ARQ 531, AKT inhibitors, miransertib and ARQ 751, as well as FGFR inhibitor, derazantinib. The oral presentation will highlight data from a...

Full description

Saved in:
Bibliographic Details
Published inHealth & Beauty Close - Up
Format Newsletter
LanguageEnglish
Published Jacksonville Close-Up Media, Inc 19.03.2018
Subjects
Online AccessGet full text

Cover

Loading…